Catalyst Event
Merck and Co Inc (MRK) · Other
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
3/18/2026, 12:00:00 AM
Merck's Animal Health unit received FDA approval on March 18, 2026, for an expanded label for Bravecto Quantum, a once-yearly injectable parasiticide for dogs, to treat and control Asian longhorned and Gulf Coast ticks.
Korean Translation
머크의 동물 의약품 사업부가 2026년 3월 18일, 1년 1회 주사하는 반려견용 구충제 브라벡토 퀀텀(Bravecto Quantum)에 대해 아시아 긴뿔 진드기 및 걸프 코스트 진드기 치료 및 제어를 포함하도록 확대된 라벨을 FDA로부터 승인받음.
Related Recent Events
Lululemon Athletica Inc (LULU) · Earnings Release
Q1 2026 earnings release scheduled. This is an estimated date based on past reporting schedules.
5/28/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release scheduled; a price impact of at least 1% is expected.
4/30/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Q1 2026 earnings release with adjusted EPS guidance of $1.12 to $1.18, for which a ≥1% price impact is estimated, scheduled.
4/15/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Other
Quarterly dividend ex-date of $0.63 per share on 2026-04-15, for which a ≥1% price impact is estimated, scheduled.
4/15/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
New target action date for the FDA's decision on oral obesity drug orforglipron, following an extension of the review period announced on January 15, 2026, scheduled; a price impact of at least 1% is expected.
4/10/2026, 12:00:00 AM
DICK'S Sporting Goods Inc (DKS) · Other
Quarterly dividend of $1.25 per share, a 3% increase, will have its ex-dividend date on March 27, 2026. The dividend is payable on April 10, 2026. A 1% price impact is estimated due to the dividend increase, scheduled.
3/27/2026, 12:00:00 AM